CTI BioPharma Corp. (CTIC) - NASDAQ
From other sites
Company Description
CTI BioPharma Corp. operates as a biopharmaceutical company, which is focused on the acquisition, development, and commercialization of less toxic and more effective ways to treat cancer. Its products include Pixuvri, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States